GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the dual agonist tirzepatide are backed by STEP ( The New England Journal of Medicine , 2021), SURMOUNT (NEJM, 2022), and SURMOUNT-OSA (NEJM, 2024)
According to Cleveland Clinics overview of growth hormone deficiency, growth hormone plays a wide-ranging role in metabolism, bone density, and body composition throughout adulthood, which helps explain why growth hormone peptides are of interest well beyond athletic performance
Using Semaglutide Under Medical Supervision Of all the medications in its category, semaglutides potential for misuse and addiction is the highest
Emerging Vision Loss Litigation Trends The NAION litigation has rapidly evolved into a parallel track alongside gastroparesis claims, with over 30 plaintiffs petitioning New Jersey State Court for multicounty litigation (MCL) designation to consolidate vision loss cases separately from the federal Ozempic MDL